Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
President and CEO, Director
-
Stock Symbol
-
MDGL on Nasdaq
William John Sibold - trading volume in the past year for Madrigal Pharmaceuticals, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock |
55.9K |
$13.6M |
$243.83 |
Sep 9, 2024 |
Direct |
|
|
Market Stock Unit |
12.3K |
$2.99M |
$243.92 |
Jan 23, 2024 |
Direct |
Common Stock |
|
Performance Restricted Stock Units |
50K |
|
|
Sep 11, 2023 |
Direct |
Common Stock |
|
Stock Option (Right to Buy) |
18.5K |
|
|
Jan 23, 2024 |
Direct |
Common Stock |
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.